Liraglutide
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Novo Nordisk · Phase 3 · Completed · Enrollment 846
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Lira 3.0 mg | 138 participants | 66 participants | 108 participants | n/r | n/r |
| Lira 1.8 mg | 66 participants | 21 participants | 37 participants | n/r | n/r |
| Placebo | 29 participants | 12 participants | 27 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.